These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25731750)

  • 1. Conformation of BCL-XL upon Membrane Integration.
    Yao Y; Fujimoto LM; Hirshman N; Bobkov AA; Antignani A; Youle RJ; Marassi FM
    J Mol Biol; 2015 Jul; 427(13):2262-70. PubMed ID: 25731750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the membrane-inserted C-terminus of cytoprotective BCL-XL.
    Yao Y; Nisan D; Fujimoto LM; Antignani A; Barnes A; Tjandra N; Youle RJ; Marassi FM
    Protein Expr Purif; 2016 Jun; 122():56-63. PubMed ID: 26923059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL.
    Malia TJ; Wagner G
    Biochemistry; 2007 Jan; 46(2):514-25. PubMed ID: 17209561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1.
    Feng W; Huang S; Wu H; Zhang M
    J Mol Biol; 2007 Sep; 372(1):223-35. PubMed ID: 17659302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that membrane insertion of the cytosolic domain of Bcl-xL is governed by an electrostatic mechanism.
    Thuduppathy GR; Craig JW; Kholodenko V; Schon A; Hill RB
    J Mol Biol; 2006 Jun; 359(4):1045-58. PubMed ID: 16650855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
    Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
    J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-modulation of membrane insertion and refolding of the apoptotic inhibitor Bcl-xL.
    Vasquez-Montes V; Vargas-Uribe M; Pandey NK; Rodnin MV; Langen R; Ladokhin AS
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):691-700. PubMed ID: 31004798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR studies of the anti-apoptotic protein Bcl-xL in micelles.
    Losonczi JA; Olejniczak ET; Betz SF; Harlan JE; Mack J; Fesik SW
    Biochemistry; 2000 Sep; 39(36):11024-33. PubMed ID: 10998239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the structural difference between Bax-α5 and Bcl-xL-α5 on their interactions with lipid bilayers.
    Han E; Lee H
    Phys Chem Chem Phys; 2014 Jan; 16(3):981-8. PubMed ID: 24281254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles.
    Yao H; Mi S; Gong W; Lin J; Xu N; Perrett S; Xia B; Wang J; Feng Y
    Biochemistry; 2013 Sep; 52(37):6324-34. PubMed ID: 23977882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL.
    Parikh N; Koshy C; Dhayabaran V; Perumalsamy LR; Sowdhamini R; Sarin A
    BMC Cell Biol; 2007 May; 8():16. PubMed ID: 17519046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure assembly of Bcl-x(L) through alpha5-alpha5 and alpha6-alpha6 interhelix interactions in lipid membranes.
    Feng Y; Liu D; Shen X; Chen K; Jiang H
    Biochim Biophys Acta; 2009 Nov; 1788(11):2389-95. PubMed ID: 19761754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid destabilization of the solution conformation of Bcl-xL does not drive its pH-dependent insertion into membranes.
    Thuduppathy GR; Hill RB
    Protein Sci; 2006 Feb; 15(2):248-57. PubMed ID: 16385002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal domain of Bcl-xL reversibly binds membranes in a pH-dependent manner.
    Thuduppathy GR; Terrones O; Craig JW; Basañez G; Hill RB
    Biochemistry; 2006 Dec; 45(48):14533-42. PubMed ID: 17128992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles.
    Denisov AY; Chen G; Sprules T; Moldoveanu T; Beauparlant P; Gehring K
    Biochemistry; 2006 Feb; 45(7):2250-6. PubMed ID: 16475813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Cardiolipin on the Conformational Dynamics of Membrane-Anchored Bcl-xL.
    Tyagi V; Vasquez-Montes V; Freites JA; Kyrychenko A; Tobias DJ; Ladokhin AS
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into mouse anti-apoptotic Bcl-xl reveal affinity for Beclin 1 and gossypol.
    Priyadarshi A; Roy A; Kim KS; Kim EE; Hwang KY
    Biochem Biophys Res Commun; 2010 Apr; 394(3):515-21. PubMed ID: 20206602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl.
    Xu H; Tai J; Ye H; Kang CB; Yoon HS
    Biochem Biophys Res Commun; 2006 Mar; 341(4):938-44. PubMed ID: 16455050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helix orientations in membrane-associated Bcl-X(L) determined by 15N-solid-state NMR spectroscopy.
    Aisenbrey C; Sudheendra US; Ridley H; Bertani P; Marquette A; Nedelkina S; Lakey JH; Bechinger B
    Eur Biophys J; 2007 Dec; 37(1):71-80. PubMed ID: 17492281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational Switching in Bcl-xL: Enabling Non-Canonic Inhibition of Apoptosis Involves Multiple Intermediates and Lipid Interactions.
    Vasquez-Montes V; Kyrychenko A; Vargas-Uribe M; Rodnin MV; Ladokhin AS
    Cells; 2020 Feb; 9(3):. PubMed ID: 32111007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.